MACROGENICS INC — Director's Dealing 2016

Feb 29, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2016-02-25

Reporting Person: Wigginton Jon Marc (Sr VP, Clinical Dev & CMO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-25	Common Stock	A	30000	—	Acquired	30000	Direct

Footnotes

F1: Consists of restricted stock units granted under the MacroGenics 2013 Equity Incentive Plan.

F2: These restricted stock units will vest on February 25, 2018, subject to continued employment with the Company, or earlier upon termination, other than for cause. Upon vesting, each restricted stock award will convert into one share of common stock of the Company